Trial Profile
A Phase I, Double Blind, Randomized, Placebo Controlled, Maximal Dose Study to Determine the Safety, Tolerability of Topical Cream Containing MGC (Medical Grade Cannabis) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Mar 2019
Price :
$35
*
At a glance
- Drugs Marijuana (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- Sponsors One World Cannabis
- 30 Jan 2019 Results presented in an OWC Pharmaceutical Research Corp Media Release.
- 30 Jan 2019 According to an OWC Pharmaceutical Research Corp media release, this study was conducted between September 2017 when the first subject entered the study and January 2019 when the last subjected completed the study.
- 30 Jan 2019 Status changed from recruiting to completed, according to an OWC Pharmaceutical Research Corp media release.